Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2289]

I-SPY 2 trial shows promising development for some breast cancer patients using...

Dr John W. Park - University of California, San Francisco Hellen Diller Family...

I-SPY 2 trial shows promising development for some breast cancer patients using neratinib ( Dr John W. Park - University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, USA )

Obesity and diabetes should be taken into account when planning breast cancer...

Dr Caterina Fontanella - German Breast Group, Neu-Isenberg, Germany

Obesity and diabetes should be taken into account when planning breast cancer treatment ( Dr Caterina Fontanella - German Breast Group, Neu-Isenberg, Germany )

European breast screening programmes

Dr Hilary Dobson - West of Scotland Cancer Network, Glasgow, UK

European breast screening programmes ( Dr Hilary Dobson - West of Scotland Cancer Network, Glasgow, UK )

Consensus on the treatment of breast cancer and early intervention using...

Prof Nadia Harbeck - University of Munich, Munich, Germany

Consensus on the treatment of breast cancer and early intervention using endocrine therapy ( Prof Nadia Harbeck - University of Munich, Munich, Germany )

Ganetespib in first-line treatment of women with metastatic HER2 positive or...

Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK

Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )

Radiotherapy after mastectomy benefit for breast cancer that has spread to just...

Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan

Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes ( Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan )

Mechanisms of action and robotics in mCRPC

Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China

Mechanisms of action and robotics in mCRPC ( Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China )

The future of mCRPC treatment - expert discussion

Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and...

The future of mCRPC treatment - expert discussion ( Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and Prof Paul de Souza - University of Western Sydney, Sydney, Australia )

Sharing Indian perspectives on CRPC

Dr Senthil Rajippa - Kidwai Memorial Institute of Oncology, Bangalore, India

Sharing Indian perspectives on CRPC ( Dr Senthil Rajippa - Kidwai Memorial Institute of Oncology, Bangalore, India )

ecancermedicalscience Editor's Choice for March 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience Editor's Choice for March 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

EURECA project: Architecture, standards and integration

Kristof De Schepper - Custodix, Sint-Martens-Latem, Belgium

EURECA project: Architecture, standards and integration ( Kristof De Schepper - Custodix, Sint-Martens-Latem, Belgium )

PSA as a marker of disease in patients with prostate cancer and bone metastases

Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal

PSA as a marker of disease in patients with prostate cancer and bone metastases ( Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal )

More from ecancer